Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000899243-18-006557
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-06 20:32:08
Reporting Period:
2018-03-02
Accepted Time:
2018-03-06 20:32:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1623613 Mylan N.v. MYL Pharmaceutical Preparations (2834) 981189497
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1657568 Paul Campbell Building 4, Trident Place, Mosquito Way
Hatfield, Hertfordshire X0 AL10 9UL
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2018-03-03 831 $0.00 17,054 No 4 M Direct
Ordinary Shares Disposition 2018-03-03 357 $40.97 16,697 No 4 F Direct
Ordinary Shares Acquisiton 2018-03-03 220 $0.00 220 No 4 M Indirect By Spouse
Ordinary Shares Disposition 2018-03-03 75 $40.97 145 No 4 F Indirect By Spouse
Ordinary Shares Acquisiton 2018-03-04 480 $0.00 17,177 No 4 X Direct
Ordinary Shares Disposition 2018-03-04 206 $40.97 16,971 No 4 F Direct
Ordinary Shares Acquisiton 2018-03-04 190 $0.00 335 No 4 X Indirect By Spouse
Ordinary Shares Disposition 2018-03-04 65 $40.97 270 No 4 F Indirect By Spouse
Ordinary Shares Acquisiton 2018-03-04 1,081 $0.00 18,052 No 4 M Direct
Ordinary Shares Disposition 2018-03-04 530 $40.97 17,522 No 4 F Direct
Ordinary Shares Acquisiton 2018-03-06 7,030 $11.18 24,552 No 4 X Direct
Ordinary Shares Disposition 2018-03-06 7,030 $44.01 17,522 No 4 S Direct
Ordinary Shares Acquisiton 2018-03-06 5,766 $12.15 23,288 No 4 X Direct
Ordinary Shares Disposition 2018-03-06 1,621 $43.23 21,667 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Indirect By Spouse
No 4 F Indirect By Spouse
No 4 X Direct
No 4 F Direct
No 4 X Indirect By Spouse
No 4 F Indirect By Spouse
No 4 M Direct
No 4 F Direct
No 4 X Direct
No 4 S Direct
No 4 X Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Employee Stock Option - Right to Buy Acquisiton 2018-03-02 9,681 $0.00 9,681 $40.97
Ordinary Shares Employee Stock Option - Right to Buy Acquisiton 2018-03-02 612 $0.00 612 $40.97
Ordinary Shares Restricted Stock Units Acquisiton 2018-03-02 5,940 $0.00 5,940 $0.00
Ordinary Shares Restricted Stock Units Acquisiton 2018-03-02 501 $0.00 501 $0.00
Ordinary Shares Restricted Stock Units Disposition 2018-03-03 831 $0.00 831 $0.00
Ordinary Shares Restricted Stock Units Disposition 2018-03-03 220 $0.00 220 $0.00
Ordinary Shares Restricted Stock Units Disposition 2018-03-04 480 $0.00 480 $0.00
Ordinary Shares Restricted Stock Units Disposition 2018-03-04 190 $0.00 190 $0.00
Ordinary Shares Performance Restricted Stock Units Disposition 2018-03-04 1,081 $0.00 1,081 $0.00
Ordinary Shares Employee Stock Option - Right to Buy Disposition 2018-03-06 7,030 $0.00 7,030 $11.18
Ordinary Shares Employee Stock Option - Right to Buy Disposition 2018-03-06 5,766 $0.00 5,766 $12.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,681 2028-03-02 No 4 A Direct
612 2028-03-02 No 4 A Indirect
5,940 No 4 A Direct
501 No 4 A Indirect
1,660 No 4 M Direct
439 No 4 M Indirect
0 No 4 X Direct
0 No 4 X Indirect
0 No 4 M Direct
0 2018-03-18 No 4 X Direct
11,533 2009-03-05 No 4 X Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 318 Indirect By 401(k) Plan
Footnotes
  1. Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 3, 2017.
  2. Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2015.
  3. Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of the performance restricted stock units (PRSUs) granted on March 4, 2015.
  4. Represents the acquisition of Mylan ordinary shares upon exercise of stock options granted on March 18, 2008.
  5. Represents the acquisition of Mylan ordinary shares upon exercise of stock options granted on March 5, 2009.
  6. Represents the delivery of ordinary shares to satisfy the exercise price associated with the exercise of stock options granted on March 5, 2009.
  7. These options vest in three equal annual installments beginning on March 2, 2019 and expire on March 2, 2028.
  8. Each RSU represents the right to receive one ordinary share of Mylan N.V. The RSUs vest in three equal annual installments beginning on March 2, 2019.
  9. Each RSU represents the right to receive one ordinary share of Mylan N.V. 831 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 830 will vest on March 3, 2019, and 830 will vest on March 3, 2020.
  10. Each RSU represents the right to receive one ordinary share of Mylan N.V. 220 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 219 will vest on March 3, 2019, and 220 will vest on March 3, 2020.
  11. Each RSU represents the right to receive one ordinary share of Mylan N.V. 481 of the RSUs granted on March 4, 2015 vested on March 4, 2016, and 480 vested on each of March 4, 2017 and March 4, 2018.
  12. Each RSU represents the right to receive one ordinary share of Mylan N.V. 190 of the RSUs granted on March 4, 2015 vested on March 4, 2016, 189 vested on March 4, 2017, and 190 vested on March 4, 2018.
  13. Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on March 4, 2015, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs fully vested on March 4, 2018.
  14. The grant, of which these options were a part, vested in three equal installments beginning on March 18, 2009.
  15. The grant, of which these options were a part, vested in three equal installments beginning on March 5, 2010.